X-66599723-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021783.5(EDA2R):c.655G>A(p.Glu219Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,207,935 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021783.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA2R | ENST00000374719.8 | c.655G>A | p.Glu219Lys | missense_variant | 6/7 | 1 | NM_021783.5 | ENSP00000363851.3 | ||
EDA2R | ENST00000253392.5 | c.718G>A | p.Glu240Lys | missense_variant | 6/6 | 1 | ENSP00000253392.5 | |||
EDA2R | ENST00000396050.5 | c.718G>A | p.Glu240Lys | missense_variant | 6/7 | 5 | ENSP00000379365.2 | |||
EDA2R | ENST00000451436.6 | c.655G>A | p.Glu219Lys | missense_variant | 6/7 | 5 | ENSP00000415242.3 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111443Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33639
GnomAD3 exomes AF: 0.0000393 AC: 7AN: 178057Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 63169
GnomAD4 exome AF: 0.0000410 AC: 45AN: 1096492Hom.: 0 Cov.: 32 AF XY: 0.0000442 AC XY: 16AN XY: 362076
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111443Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33639
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2024 | The c.718G>A (p.E240K) alteration is located in exon 6 (coding exon 6) of the EDA2R gene. This alteration results from a G to A substitution at nucleotide position 718, causing the glutamic acid (E) at amino acid position 240 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at